Department of Cardiology/Angiology, Heart Center Siegburg, Siegburg, Germany.
EuroIntervention. 2011 Feb;6(7):889-92. doi: 10.4244/EIJV6I7A151.
We present our first clinical experience to substitute ethanol with special designed microspheres in a TASH procedure (transcatheter ablation of septal hypertrophy). TASH is a standard approach for the treatment of patients with hypertrophic obstructive cardiomyopathy, severely symptomatic despite maximal medical therapy. However, the injection of alcohol remains a source of some possible complications.
We substituted alcohol with special designed microspheres. A highly symptomatic HOCM patient underwent a procedure of percutaneous ablation of his hypertrophied septum with the use of Embozene microspheres. The procedure was successful, as the gradient was reduced from 70 before the procedure to 10 mmHg afterwards.
TASH by means of microspheres embolisation instead of alcohol was a safe and successful in the short-term procedure.
我们报告首例应用特殊设计的微球替代乙醇进行酒精室间隔消融术(TASH)的临床经验。TASH 是治疗梗阻性肥厚型心肌病(HOCM)患者的标准方法,这些患者尽管接受了最大程度的药物治疗,但仍有严重的症状。然而,注射乙醇仍然存在一些潜在并发症的风险。
我们用特殊设计的微球替代了乙醇。一名症状严重的 HOCM 患者接受了经皮酒精室间隔消融术,使用了 Embozene 微球。该手术非常成功,梯度从术前的 70mmHg 降至术后的 10mmHg。
微球栓塞而非乙醇的 TASH 是一种安全有效的短期治疗方法。